| Type | Title | Date Released | |
|---|---|---|---|
SCHEDULE 13G/A | BERKLEY W R CORP (Filed by) New | ||
SCHEDULE 13G/A | WOLVERINE ASSET MANAGEMENT LLC (Filed by) | ||
8-K | Black Hawk Acquisition Corporation Extends Business Combination Period to November 2026 | ||
8-K | Black Hawk Acquisition Corporation Shareholders Approve Business Combination with Vesicor Therapeutics | ||
SCHEDULE 13G/A | WOLVERINE ASSET MANAGEMENT LLC (Filed by) | ||
10-Q | Form 10-Q | ||
425 | Form 425 | ||
8-K | Black Hawk Acquisition Corporation Enters into Financing and Related Agreements with Meteora for Business Combination with Vesicor Therapeutics | ||
8-K | Black Hawk Acquisition Corporation Extends Business Combination Deadline to October 22, 2026 | ||
424B4 | Form 424B4 | ||
EFFECT | Form EFFECT | ||
S-4/A | Black Hawk Acquisition Corporation Announces Special Meeting to Approve Business Combination with Vesicor Therapeutics, Inc. EFFECTIVE, DATED 2026-09-17 |
